ofloxacin has been researched along with cefixime in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 7 (26.92) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Kumamoto, Y | 1 |
| Hirose, T; Kumamoto, Y; Nishimura, M; Ohya, S; Shibuya, A; Tsukamoto, T | 1 |
| Arakawa, M; Muramatsu, Y; Ozaki, K; Satou, T; Takano, M; Tasaki, K; Wada, K | 1 |
| Leshem, Y; Raz, R; Rottensterich, E; Tabenkin, H | 1 |
| Bakst, CM; Loughlin, KA; Rybak, MJ | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Marshall, SA; Murray, PR; Washington, JA | 1 |
| Mann, RD; Pearce, GL; Wilton, LV | 1 |
| Cao, XT; Kneen, R; Nguyen, TA; Parry, CM; Truong, DL; White, NJ | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Chai, SE; Choi, HY; Hyun, JH; Jeon, SS; Woo, SH | 1 |
| Kabra, SK; Kadhiravan, T; Kapil, A; Misra, A; Renuka, K; Wig, N | 1 |
| Brückner, O; Trautmann, M | 1 |
| Beksac, MS; Katlan, D; Kir, S; Nemutlu, E; Ozyüncü, O | 1 |
| Babu, P; Bakthavatchalam, YD; Doss, CGP; Kumar, DT; Munusamy, E; Ravi, R; Shankar, BA; Tayubi, IA; Thukkaram, B; Veeraraghavan, B | 1 |
| Tiwaskar, M | 1 |
| Acharya, B; Arjyal, A; Karki, M; Marasini, B; Pokharel, S | 1 |
| Fazaludeen Koya, S; Galea, S; Hasan Farooqui, H; Mehta, A; Selvaraj, S | 1 |
| Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
3 review(s) available for ofloxacin and cefixime
| Article | Year |
|---|---|
Oral treatment of gonorrhea and chlamydia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Chlamydia Infections; Ciprofloxacin; Doxycycline; Female; Gonorrhea; Guidelines as Topic; Humans; Male; Ofloxacin; Randomized Controlled Trials as Topic | 1994 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for ofloxacin and cefixime
| Article | Year |
|---|---|
Single-dose treatment of female acute uncomplicated cystitis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Clinical Protocols; Colony Count, Microbial; Cystitis; Fluoroquinolones; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urine | 1992 |
Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefixime; Cefotaxime; Double-Blind Method; Female; Humans; Middle Aged; Ofloxacin; Urinary Tract Infections | 1994 |
A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group.
Topics: Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Male; Ofloxacin; Typhoid Fever | 1999 |
20 other study(ies) available for ofloxacin and cefixime
| Article | Year |
|---|---|
[A clinical study on postantibiotic effect (PAE) and its application to chemotherapy for complicated cystitis with an automatic simulator of urinary drug concentration].
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Automation; Cefixime; Cefotaxime; Cystitis; Enterobacter cloacae; Humans; Models, Biological; Ofloxacin; Staphylococcus epidermidis; Urinary Bladder | 1992 |
[An infection route of meningococcal meningitis and eradication of carriers].
Topics: Carrier State; Cefixime; Cefotaxime; Female; Humans; Meningitis, Meningococcal; Middle Aged; Ofloxacin | 1988 |
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Cefixime; Cefotaxime; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome | 1996 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy.
Topics: Adenocarcinoma; Administration, Oral; Administration, Rectal; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacterial Infections; Biomarkers, Tumor; Biopsy, Needle; Bisacodyl; Cefixime; Epididymitis; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Retrospective Studies; Risk Factors; Ultrasonography, Interventional | 2003 |
Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2005 |
Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bronchitis; Cefixime; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Empyema, Pleural; Humans; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Safety; Treatment Outcome | 1989 |
Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.
Topics: Adult; Amniocentesis; Amniotic Fluid; Anti-Bacterial Agents; Aza Compounds; Cefixime; Female; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Pregnancy; Quinolines; Statistics, Nonparametric | 2010 |
In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; Cefixime; Humans; India; Microbial Sensitivity Tests; Ofloxacin; Salmonella typhi; Typhoid Fever | 2017 |
Cefixime-ofloxacin Combination in the Management of Uncomplicated Typhoid Fever in the Indian Community Setting.
Topics: Anti-Bacterial Agents; Cefixime; Drug Combinations; Humans; India; Ofloxacin; Salmonella typhi; Typhoid Fever | 2019 |
Outbreak of acute undifferentiated febrile illness in Kathmandu, Nepal: clinical and epidemiological investigation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Disease Outbreaks; Female; Fever; Humans; Male; Middle Aged; Nepal; Ofloxacin; Risk Factors; Typhoid Fever; Virus Diseases; Young Adult | 2020 |
Quantifying antibiotic use in typhoid fever in India: a cross-sectional analysis of private sector medical audit data, 2013-2015.
Topics: Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Cross-Sectional Studies; Drug Prescriptions; Female; Humans; India; Male; Medical Audit; Ofloxacin; Practice Patterns, Physicians'; Private Sector; Quinolones; Typhoid Fever; Young Adult | 2022 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |